Slingshot members are tracking this event:

Allergran (AGN) and Paratek (PRTK) set to file NDA for Sarecycline, an antibiotic designed to treat inflammatory acne, in 2H 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
AGN Community voting in process
PRTK Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Sarecycline, Inflammatory Acne